AVE Science & Technology Co Ltd (688067) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.029x

Based on the latest financial reports, AVE Science & Technology Co Ltd (688067) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.02 Million ≈ $2.20 Million USD) by net assets (CN¥518.37 Million ≈ $75.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688067 company net worth for the company's overall valuation and market capitalisation.

AVE Science & Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how AVE Science & Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

AVE Science & Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AVE Science & Technology Co Ltd ranked by their cash flow conversion efficiency. Explore AVE Science & Technology Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Asia Cement
KO:002030
0.032x
Hyundai Cement
KO:006390
0.059x
Asure Software Inc
NASDAQ:ASUR
0.023x
Nu Skin Enterprises Inc
NYSE:NUS
0.020x
Illumination Acquisition Corp I Class A Ordinary Shares
NASDAQ:ILLU
N/A
Astral Resources NL
AU:AAR
-0.011x
Warriedar Resources Ltd
AU:WA8
0.016x
Easy Trip Planners Limited
NSE:EASEMYTRIP
-0.020x

Annual Cash Flow Conversion Efficiency for AVE Science & Technology Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of AVE Science & Technology Co Ltd from 2012 to 2024. View 688067 stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥495.85 Million
≈ $72.56 Million
CN¥22.41 Million
≈ $3.28 Million
0.045x -2.60%
2023-12-31 CN¥489.84 Million
≈ $71.68 Million
CN¥22.73 Million
≈ $3.33 Million
0.046x -25.87%
2022-12-31 CN¥475.12 Million
≈ $69.52 Million
CN¥29.74 Million
≈ $4.35 Million
0.063x -36.65%
2021-12-31 CN¥477.58 Million
≈ $69.88 Million
CN¥47.19 Million
≈ $6.90 Million
0.099x -50.17%
2020-12-31 CN¥236.72 Million
≈ $34.64 Million
CN¥46.93 Million
≈ $6.87 Million
0.198x -19.38%
2019-12-31 CN¥252.51 Million
≈ $36.95 Million
CN¥62.10 Million
≈ $9.09 Million
0.246x +32.38%
2018-12-31 CN¥217.27 Million
≈ $31.79 Million
CN¥40.36 Million
≈ $5.91 Million
0.186x +42.49%
2017-12-31 CN¥189.95 Million
≈ $27.80 Million
CN¥24.76 Million
≈ $3.62 Million
0.130x -25.67%
2016-12-31 CN¥177.84 Million
≈ $26.02 Million
CN¥31.19 Million
≈ $4.56 Million
0.175x +21.23%
2015-12-31 CN¥147.53 Million
≈ $21.59 Million
CN¥21.35 Million
≈ $3.12 Million
0.145x -14.61%
2014-12-31 CN¥138.28 Million
≈ $20.24 Million
CN¥23.43 Million
≈ $3.43 Million
0.169x +38.06%
2013-12-31 CN¥121.15 Million
≈ $17.73 Million
CN¥14.87 Million
≈ $2.18 Million
0.123x -6.50%
2012-12-31 CN¥103.11 Million
≈ $15.09 Million
CN¥13.53 Million
≈ $1.98 Million
0.131x --

About AVE Science & Technology Co Ltd

SHG:688067 China Medical Instruments & Supplies
Market Cap
$235.83 Million
CN¥1.61 Billion CNY
Market Cap Rank
#16032 Global
#4619 in China
Share Price
CN¥23.70
Change (1 day)
+1.72%
52-Week Range
CN¥18.15 - CN¥29.63
All Time High
CN¥37.29
About

AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment China, Europe, the United States, Asia, Africa, and internationally. The company offers urine formed elements analyzer and related reagents, automatic urine ana… Read more